CALGARY, ALBERTA--(Marketwired - Sept. 24, 2013) - The Fraser Institute will release a new study Wednesday, September 25 outlining how Canadians could gain faster access to new medicines that could help alleviate pain and suffering stemming from major illnesses.
Many new medicines that could help Canadians suffering from life-threatening diseases are often unavailable because they have yet to be approved by Health Canada. Meanwhile, these same medicines are often already widely available in the European Union or the United States.
A news release with additional information will be issued via Marketwired at 6:30 a.m. (Eastern) on Wednesday, September 25.
The full report will also be available as a free PDF download at www.fraserinstitute.org.
Follow the Fraser Institute on Twitter and Facebook
The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of 86 think-tanks. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org